The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
The effects of antipsychotic therapy on serum lipids: a comprehensive review
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Antipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382
Consensus development conference on antipsychotic drugs and obesity and diabetes
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity (2004) · Diabetes Care · doi:10.2337/diacare.27.2.596 · Cited by 1,554
The unhealthy lifestyle of people with schizophrenia
BROWN, S., BIRTWISTLE, J., ROE, L., & THOMPSON, C. (1999) · Psychological Medicine · doi:10.1017/s0033291798008186 · Cited by 874
The Obesity Epidemic: Pathophysiology and Consequences of Obesity
Pi‐Sunyer, F. X. (2002) · Obesity Research · doi:10.1038/oby.2002.202 · Cited by 858
Kroeze, W. K., Hufeisen, S. J., Popadak, B. A., Renock, S. M., Steinberg, S., Ernsberger, P., Jayathilake, K., Meltzer, H. Y., & Roth, B. L. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300027 · Cited by 801
Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study
Henderson, D. C., Cagliero, E., Gray, C., Nasrallah, R. A., Hayden, D. L., Schoenfeld, D. A., & Goff, D. C. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.975 · Cited by 701
Mortality and causes of death in schizophrenia in Stockholm County, Sweden
Ösby, U., Correia, N., Brandt, L., Ekbom, A., & Sparén, P. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00191-7 · Cited by 679 · cited 2×
“The net impact on mortality in the schizophrenia population can be seen in the results of large epidemiologic studies (Osby et al., 2000) which have noted a standardized mortality ratio from cardiovascular disease twofold greater for schizophrenia patients than the general population.”
BackgroundJeppesen, J. Ø., Hein, H. O., Suadicani, P., & Gyntelberg, F. (1998) · Circulation · doi:10.1161/01.cir.97.11.1029 · Cited by 676
Jenkins, D. J. A. (2003) · JAMA · doi:10.1001/jama.290.4.502 · Cited by 620
Hypertriglyceridemia, insulin resistance, and the metabolic syndrome
Grundy, S. M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00211-8 · Cited by 610
Csernansky, J. G., Mahmoud, R., & Brenner, R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa002028 · Cited by 605
Potkin, S. G., Saha, A. R., Kujawa, M. J., Carson, W. H., Ali, M., Stock, E., Stringfellow, J., Ingenito, G., & Marder, S. R. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.681 · Cited by 591
Prevalence and Correlates of Diabetes in National Schizophrenia Samples
Dixon, L., Weiden, P., Delahanty, J., Goldberg, R., Postrado, L., Lucksted, A., & Lehman, A. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033504 · Cited by 569
Mortality and Causes of Death in First Admitted Schizophrenic Patients
Mortensen, P. B., & Juel, K. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.163.2.183 · Cited by 412
Novel antipsychotics and new onset diabetes
Wirshing, D. A., Spellberg, B. J., Erhart, S. M., Marder, S. R., & Wirshing, W. C. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00100-0 · Cited by 407
A Comparative Review On Aggression Konrad Lorenz The Territorial Imperative Robert Ardrey
Alexander, R. D., & Tinkle, D. W. (1968) · BioScience · doi:10.2307/1294259 · Cited by 397
Zimmermann, U., Kraus, T., Himmerich, H., Schuld, A., & Pollmächer, T. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00018-9 · Cited by 347
Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.
Kinon, B. J., Basson, B. R., Gilmore, J. A., & Tollefson, G. D. (2001) · PubMed · Cited by 317
Melkersson, K. I., Hulting, A.-L., & Brismar, K. E. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1006 · Cited by 299
The Effects of Novel Antipsychotics on Glucose and Lipid Levels
Wirshing, D. A., Jennifer A., J. A., Meng, L. R., Ballon, J. S., Marder, S. R., & Wirshing, W. C. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1002 · Cited by 294
Long-Term Olanzapine Treatment: Weight Change and Weight-Related Health Factors in Schizophrenia
Kinon, B. J., Basson, B. R., Gilmore, J. A., & Tollefson, G. D. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0204 · Cited by 269
Meyer, J. M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0509 · Cited by 267
Self-citationAntipsychotic Metabolic Effects: Weight Gain, Diabetes Mellitus, and Lipid Abnormalities
McIntyre, R. S., McCann, S. M., & Kennedy, S. H. (2001) · The Canadian Journal of Psychiatry · doi:10.1177/070674370104600308 · Cited by 261
Cardiovascular Risk Factors for People with Mental Illness
Davidson, S., Judd, F., Jolley, D., Hocking, B., Thompson, S., & Hyland, B. (2001) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2001.00877.x · Cited by 249
Jin, H., Meyer, J. M., & Jeste, D. V. (2002) · Annals of Clinical Psychiatry · doi:10.1023/a:1015228112495 · Cited by 249
Self-citationClozapine-induced weight gain: prevalence and clinical relevance
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.1.68 · Cited by 248
Koro, C. E., Fedder, D. O., L'Italien, G. J., Weiss, S., Magder, L. S., Kreyenbuhl, J., Revicki, D., & Buchanan, R. W. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.11.1021 · Cited by 234
Self-citationBodyweight Gain with Atypical Antipsychotics: A Comparative Review
Wetterling, T. (2001) · Drug Safety · doi:10.2165/00002018-200124010-00005 · Cited by 231
Olanzapine Increases Weight and Serum Triglyceride Levels
Osser, D. N., Najarian, D. M., & Dufresne, R. L. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1109 · Cited by 229
Body Weight and Leptin Plasma Levels During Treatment With Antipsychotic Drugs
Kraus, T., Haack, M., Schuld, A., Hinze-Selch, D., K�hn, M., Uhr, M., & Pollm�cher, T. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.312 · Cited by 221
Pharmacologic activation of limbic structures and neuroimaging studies of emotions.
Beasley, C. M., Tollefson, G. D., & Tran, P. V. (1997) · PubMed · Cited by 197
Lund, B. C., Perry, P. J., Brooks, J. M., & Arndt, S. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.12.1172 · Cited by 194
Serum Leptin and Triglyceride Levels in Patients on Treatment With Atypical Antipsychotics
Atmaca, M., Kuloglu, M., Tezcan, E., & Ustundag, B. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0516 · Cited by 181
Association of Olanzapine-Induced Weight Gain With an Increase in Body Fat
Eder, U., Mangweth, B., Ebenbichler, C., Weiss, E., Hofer, A., Hummer, M., Kemmler, G., Lechleitner, M., & Fleischhacker, W. W. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.10.1719 · Cited by 181
Umbricht, D., Pollack, S. Z., & Kane, J. (1994) · PubMed · Cited by 179
Olanzapine-Induced Ketoacidosis With Diabetes Mellitus
LINDENMAYER, J., & PATEL, R. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1471 · Cited by 169
Novel Antipsychotics and Severe Hyperlipidemia
Meyer, J. M. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200108000-00003 · Cited by 168
Self-citationPatients on Atypical Antipsychotic Drugs
Lean, M. E. J., & Pajonk, F.-G. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1597 · Cited by 165
Differential effect of clozapine on weight: a controlled study
Bustillo, J., Buchanan, R. W., Irish, D., & Breier, A. F. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.6.817 · Cited by 157
Epidemiology of hypertriglyceridemia and cardiovascular disease
Austin, M. A. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00209-x · Cited by 138
Aripiprazole: profile on efficacy and safety
Goodnick, P. J., & Jerry, J. M. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.12.1773 · Cited by 130
Mantel-Teeuwisse, A. K., Kloosterman, J. M. E., der Zee, A. H. M., Klungel, O. H., Porsius, A. J., & de Boer, A. (2001) · Drug Safety · doi:10.2165/00002018-200124060-00003 · Cited by 127
The Mount Sinai Conference on the Pharmacotherapy of Schizophrenia
Marder, S. R., Essock, S. M., Miller, A. L., Buchanan, R. W., Davis, J. M., Kane, J. M., Lieberman, J. A., & Schooler, N. R. (2002) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a006926 · Cited by 127
Improvement In Indices Of Health Status In Outpatients With Schizophrenia Switched To Ziprasidone
Weiden, P. J., Daniel, D. G., Simpson, G. M., & Romano, S. J. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000095347.32154.08 · Cited by 123
Clozapine-Associated Elevation in Serum Triglycerides
Gaulin, B. D., Markowitz, J. S., Caley, C. F., Nesbitt, L. A., & Dufresne, R. L. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1270 · Cited by 119
Effects of atypical antipsychotics on weight and serum lipid levels.
Meyer, J. M. (2001) · PubMed · Cited by 117
Self-citationA Study of Quetiapine: Efficacy and Tolerability in Psychotic Adolescents
Shaw, J. A., Lewis, J. E., Pascal, S., Sharma, R., Rodriguez, R. A., Guillen, R., & Pupo-Guillen, M. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454601317261591 · Cited by 108
SMOKING AND CARDIOVASCULAR DISEASE
Villablanca, A. C., McDonald, J. M., & Rutledge, J. C. (2000) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(05)70015-0 · Cited by 106
Спивак, Б., Roitman, S., Vered, Y., et al. (1998) · PubMed · Cited by 97
Melkersson, K. I., & Hulting, A. (2001) · Psychopharmacology · doi:10.1007/s002130000639 · Cited by 92
ARIPIPRAZOLE: A REVIEW OF ITS PHARMACOLOGY AND CLINICAL USE
Taylor, D. M. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb11397.x · Cited by 88
Medical Illness and Schizophrenia
Meyer, J. M., & Nasrallah, H. A. (2003) · Medical Entomology and Zoology · Cited by 85
Self-citationSerum triglyceride levels in patients treated with clozapine
Ghaeli, P., & Dufresne, R. L. (1996) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/53.17.2079 · Cited by 85
Hägg, S., Söderberg, S., Åhrén, B., et al. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1102 · Cited by 80
The Apparent Effects of Ziprasidone on Plasma Lipids and Glucose
Kingsbury, S. J., Fayek, M., Trufasiu, D., Zada, J., & Simpson, G. M. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0507 · Cited by 73
Hyperlipidemia Associated with Protease Inhibitor Therapy
Echevarria, K. L., Hardin, T. C., & Smith, J. A. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18174 · Cited by 72
Triglycerides and Coronary Heart Disease: Implications of Recent Clinical Trials
Rubins, H. B. (2000) · European Journal of Cardiovascular Risk · doi:10.1177/204748730000700507 · Cited by 69 · cited 2×
“Observational studies using case-control methods and most prospective cohort studies have consistently shown a strong association of increased TG levels with CHD (Austin, 1999; Jeppesen et al., 1998; Rubins, 2000).”
MethodOlanzapine-Induced Elevation of Plasma Triglyceride Levels
Sheitman, B., BIRD, P. M., Binz, W., AKINLI, L., & SANCHEZ, C. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.9.1471-a · Cited by 69
Manfredi, R., & Chiodo, F. (2001) · Journal of Infection · doi:10.1053/jinf.2001.0829 · Cited by 67
Medical Illness and Schizophrenia
Cascella, N. G. (2004) · The Journal of Nervous and Mental Disease · doi:10.1097/01.nmd.0000144964.83457.32 · Cited by 59
The Impact of Clozapine Treatment on Serum Lipids in Chronic Schizophrenic Patients
Spivak, B., Lamschtein, C., Talmon, Y., Guy, N., Mester, R., Feinberg, I., Kotler, M., & Weizman, A. (1999) · Clinical Neuropharmacology · doi:10.1097/00002826-199903000-00006 · Cited by 57
Atmaca, M., Kuloğlu, M., Tezcan, E., Geçici, Ö., & Üstündağ, B. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00305-5 · Cited by 56
Elevated Serum Triglycerides with Clozapine Resolved with Risperidone in Four Patients
Dufresne, R. L., & Ghaeli, P. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.13.1099.31586 · Cited by 47
HALOPERIDOL, CLOPENTHIXOL, AND CHLORPROMAZINE IN CHRONIC SCHIZOPHRENIA
Serafetinides, E. A., COLLINS, S., & Clark, M. L. (1972) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197201000-00005 · Cited by 41
Triglyceride, cholesterol and weight changes among risperidone-treated youths: A retrospective study
Martin, A., & L'Ecuyer, S. (2002) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-002-0255-5 · Cited by 40
HALOPERIDOL, CLOPENTHIXOL, AND CHLORPROMAZINE IN CHRONIC SCHIZOPHRENIA
Serafetinides, E. A., WILLIS, D., & Clark, M. L. (1972) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197211000-00010 · Cited by 40
Weight gain and cardiovascular risk factors in the post-menopausal woman
Colombel, A., & Charbonnel, B. H. (1997) · Human Reproduction · doi:10.1093/humrep/12.suppl_1.134 · Cited by 39
QUETIAPINE-ASSOCIATED HYPERGLYCEMIA AND HYPERTRIGLYCERIDEMIA
Domon, S. E., & Cargile, C. S. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200205000-00004 · Cited by 37
Improving the Physical Health of Patients with Schizophrenia: Therapeutic Nihilism or Realism?
Fevre, P. D. L. (2001) · Scottish Medical Journal · doi:10.1177/003693300104600105 · Cited by 37
Hyperglycemia and Hypertriglyceridemia Secondary to Olanzapine
Domon, S. E., & Webber, J. C. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/10445460152595603 · Cited by 35
Baymiller, S. P., Ball, P. M., McMahon, R. P., & Buchanan, R. W. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00158-5 · Cited by 35
Atypical Antipsychotics and Cardiovascular Risk in Schizophrenic Patients
Bouchard, R.-H., Demers, M., Simoneau, I., Alméras, N., Villeneuve, J., Mottard, J., Cadrin, C., Lemieux, I., & Després, J. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200102000-00021 · Cited by 30
OLANZAPINE AND HYPERTRIGLYCERIDEMIA
Nguyen, M. L., & Murphy, T. K. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200102000-00006 · Cited by 28
Lipids and apolipoproteins in patients treated with major tranquilizers
Sasaki, J., FUNAKOSHI, M., & Arakawa, K. (1985) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1985.113 · Cited by 27
Hadigan, C. M. (2003) · Clinical Infectious Diseases · doi:10.1086/375887 · Cited by 25
Martínez, J. A., Velasco, J. J., & Urbistondo, M. D. (1994) · Journal of the American College of Nutrition · doi:10.1080/07315724.1994.10718394 · Cited by 24
Antidepressants and Risk of Cancer: A Case of Misguided Associations and Priorities
Theoharides, T. C., & Konstantinidou, A. D. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200302000-00001 · Cited by 23
Hyperglycemia, hyperlipemia, and periodic paralysis: a case report of new side effects of clozapine
Wu, G., Dias, P. B., Wu, C., et al. (2000) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(00)00141-x · Cited by 18
Further studies on the effect of butyrophenones on cholesterol synthesis in humans.
Gm, S., Tb, C., & Braun, G. A. (1967) · PubMed · Cited by 9
Severe Hypertriglyceridemia Associated With Olanzapine
Stoner, S. C., Dubisar, B. M., Khan, R., & Farrar, C. D. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1014a · Cited by 7
Väisänen, K., Rimón, R., Räisänen, P., & Viukari, M. (1979) · PubMed · Cited by 7
Cited by
Second-Generation (Atypical) Antipsychotics and Metabolic Effects: A Comprehensive Literature Review
Newcomer, J. W. (2005) · CNS Drugs · doi:10.2165/00023210-200519001-00001 · Cited by 1,340
Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
Nasrallah, H. A., Meyer, J. M., Goff, D. C., McEvoy, J. P., Davis, S. M., Stroup, T. S., & Lieberman, J. A. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.06.026 · Cited by 556
Self-citationAdverse Effects of Atypical Antipsychotics: Differential Risk and Clinical Implications
Haddad, P. M., & Sharma, S. G. (2007) · CNS Drugs · doi:10.2165/00023210-200721110-00004 · Cited by 456
Goodwin, G., & Consensus Group of the British Association for Psychopharmacology (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109102919 · Cited by 444
Metadata
- Authors
- Meyer, J. M., & Koro, C. E.
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2004-09
- Volume
- 70
- Issue
- 1
- Pages
- 1-17
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W2090191759
- Cited by
- 407
- References
- 85
- FWCI
- 19.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.